Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ADAM17 |
| Upstream (Parents) |
|---|
| (<<) ADAM9 → ADAM17 |
| (<<) B3GNT2 → ADAM17 |
| (<<) CRK → ADAM17 |
| (<<) CRKL → ADAM17 |
| (<<) EZR → ADAM17 |
| (<<) GAPDH → ADAM17 |
| (<<) HSPA9 → ADAM17 |
| (<<) ITGB1 → ADAM17 |
| (<<) MAP3K2 → ADAM17 |
| (<<) MAP3K3 → ADAM17 |
| (<<) MAP3K7 → ADAM17 |
| (<<) PPIB → ADAM17 |
| (<<) PTPN11 → ADAM17 |
| (<<) ROCK2 → ADAM17 |
| (<<) RRAS2 → ADAM17 |
| (<<) RYK → ADAM17 |
| (<<) SMURF1 → ADAM17 |
| (<<) SOS2 → ADAM17 |
| (<<) STAT3 → ADAM17 |
| (<<) THOC4 → ADAM17 |
| Downstream (Children) |
|---|
| ADAM17 → ACTG1 (>>) |
| ADAM17 → CASP2 (>>) |
| ADAM17 → CASP6 (>>) |
| ADAM17 → CBS (>>) |
| ADAM17 → CTNNB1 (>>) |
| ADAM17 → HMGA2 (>>) |
| ADAM17 → MBOAT2 (>>) |
| ADAM17 → NET1 (>>) |
| ADAM17 → PDIA4 (>>) |
| ADAM17 → PLAUR (>>) |
| ADAM17 → RASSF1 (>>) |
| ADAM17 → RDX (>>) |
| ADAM17 → RHOV (>>) |
| ADAM17 → SLC25A37 (>>) |
| ADAM17 → SRC (>>) |
| ADAM17 → THRB (>>) |
| ADAM17 → TP53 (>>) |
